Xu, S., Li, S., Guo, Z., Luo, J., Ellis, M. J., & Ma, C. X. (2013). Combined Targeting of mTOR and AKT is an Effective Strategy for Basal-like Breast Cancer in Patient-derived Xenograft Models.

Xu, Siguang, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, und Cynthia X. Ma. Combined Targeting of MTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-derived Xenograft Models. 2013.

Xu, Siguang, et al. Combined Targeting of MTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-derived Xenograft Models. 2013.